Rosuvastatin calcium and Tendonitis exacerbated - a phase IV clinical study of FDA data

Summary:

Tendonitis exacerbated is reported as a side effect among people who take Rosuvastatin calcium (rosuvastatin calcium), especially for people who are female, 50-59 old, have been taking the drug for 1 - 2 years also take Januvia, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Tendonitis exacerbated when taking Rosuvastatin calcium. It is created by eHealthMe based on reports of 24,757 people who have side effects when taking Rosuvastatin calcium from the FDA, and is updated regularly.

What is Rosuvastatin calcium?

Rosuvastatin calcium has active ingredients of rosuvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 25,353 Rosuvastatin calcium users. Check the latest studies of Rosuvastatin calcium.

What is Tendonitis exacerbated?

Tendonitis exacerbated (a condition that causes pain and swelling of tendons) is found to be associated with 939 drugs and 503 conditions by eHealthMe. Check the latest studies of Tendonitis exacerbated.

On Jul, 22, 2026

24,757 people reported to have side effects when taking Rosuvastatin calcium.
Among them, 148 people (0.6%) have Tendonitis exacerbated.

Could Rosuvastatin calcium cause Tendonitis exacerbated?

Among these 148 people:

How long have people been on Rosuvastatin calcium when they have Tendonitis exacerbated? *

Click here to view more results

What is the gender of people who have Tendonitis exacerbated when taking Rosuvastatin calcium? *

Click here to view

What is the age of people who have Tendonitis exacerbated when taking Rosuvastatin calcium? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Rosuvastatin calcium and have Tendonitis exacerbated?

- Check whether Tendonitis exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rosuvastatin calcium:

Rosuvastatin calcium (25,353 reports)

Tendonitis exacerbated treatments and more:

Tendonitis exacerbated (48 reports)

How severe was Tendonitis exacerbated and when was it recovered:

Tendonitis exacerbated in Rosuvastatin calcium

Expand to all the drugs that have ingredients of rosuvastatin calcium:

Tendonitis exacerbated and drugs with ingredients of rosuvastatin calcium (555 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rosuvastatin calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tendonitis exacerbated:

Tendonitis exacerbated (939 drugs)

Browse all the conditions that are associated with Tendonitis exacerbated:

Tendonitis exacerbated (503 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rosuvastatin calcium (the active ingredients of Rosuvastatin calcium) and Rosuvastatin calcium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.